Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cross-neutralisation of antibodies elicited by an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine in healthy adults against H5N1 clade 2 strains.
Höschler K, Gopal R, Andrews N, Saville M, Pepin S, Wood J, Zambon MC. Höschler K, et al. Among authors: zambon mc. Influenza Other Respir Viruses. 2007 Sep-Nov;1(5-6):199-206. doi: 10.1111/j.1750-2659.2007.00033.x. Influenza Other Respir Viruses. 2007. PMID: 19453427 Free PMC article. Clinical Trial.
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies.
Temperton NJ, Hoschler K, Major D, Nicolson C, Manvell R, Hien VM, Ha do Q, de Jong M, Zambon M, Takeuchi Y, Weiss RA. Temperton NJ, et al. Influenza Other Respir Viruses. 2007 May;1(3):105-12. doi: 10.1111/j.1750-2659.2007.00016.x. Influenza Other Respir Viruses. 2007. PMID: 19453415 Free PMC article.
Influenza.
Nicholson KG, Wood JM, Zambon M. Nicholson KG, et al. Lancet. 2003 Nov 22;362(9397):1733-45. doi: 10.1016/S0140-6736(03)14854-4. Lancet. 2003. PMID: 14643124 Free PMC article. Review.
A phase I clinical trial of a PER.C6 cell grown influenza H7 virus vaccine.
Cox RJ, Madhun AS, Hauge S, Sjursen H, Major D, Kuhne M, Höschler K, Saville M, Vogel FR, Barclay W, Donatelli I, Zambon M, Wood J, Haaheim LR. Cox RJ, et al. Vaccine. 2009 Mar 18;27(13):1889-97. doi: 10.1016/j.vaccine.2009.01.116. Epub 2009 Feb 2. Vaccine. 2009. PMID: 19368768 Clinical Trial.
Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.
WHO Writing Group; Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M, Zhang W. WHO Writing Group, et al. Influenza Other Respir Viruses. 2012 Mar;6(2):142-52, e1-5. doi: 10.1111/j.1750-2659.2011.00277.x. Epub 2011 Aug 8. Influenza Other Respir Viruses. 2012. PMID: 21819547 Free PMC article.
Phase I and II randomised trials of the safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in healthy adults.
Nolan TM, Richmond PC, Skeljo MV, Pearce G, Hartel G, Formica NT, Höschler K, Bennet J, Ryan D, Papanaoum K, Basser RL, Zambon MC. Nolan TM, et al. Among authors: zambon mc. Vaccine. 2008 Aug 5;26(33):4160-7. doi: 10.1016/j.vaccine.2008.05.077. Epub 2008 Jun 13. Vaccine. 2008. PMID: 18599164 Clinical Trial.
Reproducibility of serologic assays for influenza virus A (H5N1).
Stephenson I, Heath A, Major D, Newman RW, Hoschler K, Junzi W, Katz JM, Weir JP, Zambon MC, Wood JM. Stephenson I, et al. Among authors: zambon mc. Emerg Infect Dis. 2009 Aug;15(8):1252-9. doi: 10.3201/eid1508.081754. Emerg Infect Dis. 2009. PMID: 19751587 Free PMC article.
85 results